[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Avivagen Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Avivagen Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chemel AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chemel AB Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chemgenex Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chemgenex Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chemokine Therapeutics Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chemokine Therapeutics Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chengzhi Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chengzhi Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chi Sheng Chemical Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chi Sheng Chemical Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Advanced Technology Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Advanced Technology Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Agro-Technology Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Agro-Technology Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Animal Healthcare Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Animal Healthcare Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Bio-Med Regeneration Technology Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Bio-Med Regeneration Technology Limited Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Biologic Products, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Biologic Products, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Biopharma, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Biopharma, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Chemical & Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Chemical & Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Grand Pharmaceutical and Healthcare Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Grand Pharmaceutical and Healthcare Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Health Industries Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Health Industries Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Health Resource, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Health Resource, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Medical System Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Medical System Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Natural Investment Company Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Natural Investment Company Limited Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Nuokang Bio-Pharmaceutical Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Nuokang Bio-Pharmaceutical Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Pediatric Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Pediatric Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Pharma Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Pharma Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Pharmaceutical Group Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Pharmaceutical Group Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Polypeptide Group, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Polypeptide Group, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Renyuan International, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Renyuan International, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Shenghuo Pharmaceutical Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Shenghuo Pharmaceutical Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

China Shineway Pharmaceutical Group Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

China Shineway Pharmaceutical Group Limited Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

ChoA Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ChoA Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chong Kun Dang Pharmaceutical Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chong Kun Dang Pharmaceutical Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chongqing Huapont Pharm Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chongqing Huapont Pharm Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chongqing Lummy Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chongqing Lummy Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chongqing Taiji Industry (Group) Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chongqing Taiji Industry (Group) Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chongqing Zhifei Biological Products Co.,Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chongqing Zhifei Biological Products Co.,Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Choong Ang Vaccine Laboratory Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Choong Ang Vaccine Laboratory Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Choongwae Holdings Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Choongwae Holdings Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Choongwae Pharma Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Choongwae Pharma Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

ChronTech Pharma AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ChronTech Pharma AB Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chugai Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chugai Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chunghwa Chemical Synthesis & Biotech Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chunghwa Chemical Synthesis & Biotech Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cipher Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cipher Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cipla Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cipla Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cipla Medpro South Africa Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cipla Medpro South Africa Limited Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Opthea Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Opthea Limited Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

CK Life Sciences International Holdings Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CK Life Sciences International Holdings Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Ckd Bio Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ckd Bio Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Clavis Pharma AS Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Clavis Pharma AS Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Clearant, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Clearant, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cleveland BioLabs, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cleveland BioLabs, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Clinical Data, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Clinical Data, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers